415 related articles for article (PubMed ID: 34791940)
1. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
2. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
[TBL] [Abstract][Full Text] [Related]
4. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
6. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of multiple viruses in patients with sepsis.
Walton AH; Muenzer JT; Rasche D; Boomer JS; Sato B; Brownstein BH; Pachot A; Brooks TL; Deych E; Shannon WD; Green JM; Storch GA; Hotchkiss RS
PLoS One; 2014; 9(2):e98819. PubMed ID: 24919177
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
Tassaneeyasin T; Sungkanuparph S; Srichatrapimuk S; Charoensri A; Thammavaranucupt K; Jayanama K; Kirdlarp S
PLoS One; 2024; 19(5):e0303995. PubMed ID: 38771836
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19.
Mattei A; Schiavoni L; Riva E; Ciccozzi M; Veralli R; Urselli A; Citriniti V; Nenna A; Pascarella G; Costa F; Cataldo R; Agrò FE; Carassiti M
Intensive Care Med Exp; 2024 Apr; 12(1):40. PubMed ID: 38649512
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study.
Guiouillier F; Derely J; Salvadori A; Pochard J; Le Goff J; Martinez T; Raffin F; Laitselart P; Beaucreux C; Priou S; Conan PL; Foissaud V; Servonnet A; Vest P; Boutonnet M; de Rudnicki S; Bigaillon C; Libert N
Intensive Care Med; 2024 Mar; 50(3):418-426. PubMed ID: 38436725
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
[TBL] [Abstract][Full Text] [Related]
16. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
[TBL] [Abstract][Full Text] [Related]
17. High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.
Ogata M; Satou T; Kawano R; Yoshikawa T; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Kikuchi H; Saikawa T; Kadota J
J Med Virol; 2011 Apr; 83(4):702-9. PubMed ID: 21328386
[TBL] [Abstract][Full Text] [Related]
18. Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation.
Li SS; Zhang N; Jia M; Su M
Front Cell Infect Microbiol; 2022; 12():818167. PubMed ID: 35402291
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
20. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
